Secretin Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with secretin
H
- Haponal (atropine / hyoscyamine / phenobarbital / scopolamine)
- Hista-Vent DA (chlorpheniramine / methscopolamine / phenylephrine)
- Hista-Vent PSE (chlorpheniramine / methscopolamine / pseudoephedrine)
- Histacol LA (atropine / chlorpheniramine / hyoscyamine / phenylephrine / scopolamine)
- Histatab (chlorpheniramine / methscopolamine / pseudoephedrine)
- Histatab D (dexchlorpheniramine / methscopolamine / pseudoephedrine)
- Histatab PH (chlorpheniramine / methscopolamine / phenylephrine)
- Hyolev MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- HyoMax (hyoscyamine)
- HyoMax DT (hyoscyamine)
- HyoMax FT (hyoscyamine)
- HyoMax SL (hyoscyamine)
- HyoMax SR (hyoscyamine)
- Hyophen (benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- hyoscyamine
- hyoscyamine / methenamine
- hyoscyamine / methenamine / methylene blue / phenyl salicylate
- hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate
- hyoscyamine / methenamine / methylene blue / sodium biphosphate
- hyoscyamine / phenobarbital
- hyoscyamine / phenyltoloxamine
- Hyosol (hyoscyamine)
- Hyosophen (atropine / hyoscyamine / phenobarbital / scopolamine)
- Hyospaz (hyoscyamine)
- Hyosyne (hyoscyamine)
More about secretin
- secretin consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: in vivo diagnostic biologicals
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.